Q9Z1E4
Gene name |
Gys1 (Gys, Gys3) |
Protein name |
Glycogen [starch] synthase, muscle |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:14936 |
EC number |
2.4.1.11: Hexosyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9Z1E4
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9Z1E4-F1 | Predicted | AlphaFoldDB |
31 variants for Q9Z1E4
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3412562627 | 75 | T>M | No | EVA | |
| rs3388888272 | 81 | E>G | No | EVA | |
| rs3388867181 | 111 | G>A | No | EVA | |
| rs3388896667 | 121 | A>T | No | EVA | |
| rs3388867211 | 127 | E>D | No | EVA | |
| rs31966686 | 173 | P>L | No | EVA | |
| rs3388907196 | 188 | L>M | No | EVA | |
| rs3388882189 | 223 | N>S | No | EVA | |
| rs3397711532 | 292 | E>A | No | EVA | |
| rs3388909394 | 321 | D>V | No | EVA | |
| rs3388909354 | 325 | Y>* | No | EVA | |
| rs3388912765 | 328 | I>T | No | EVA | |
| rs3388910964 | 347 | A>P | No | EVA | |
| rs3388910979 | 354 | R>G | No | EVA | |
| rs3388907243 | 385 | V>M | No | EVA | |
| rs3388909404 | 426 | T>N | No | EVA | |
| rs3388909404 | 426 | T>S | No | EVA | |
| rs3388907274 | 450 | D>Y | No | EVA | |
| rs3388909333 | 474 | K>M | No | EVA | |
| rs1133774799 | 475 | V>E | No | EVA | |
| rs3388907438 | 480 | E>G | No | EVA | |
| rs3388890998 | 503 | G>A | No | EVA | |
| rs3388906213 | 553 | L>P | No | EVA | |
| rs3388867126 | 574 | F>L | No | EVA | |
| rs3388896694 | 611 | M>L | No | EVA | |
| rs3388900143 | 637 | P>Q | No | EVA | |
| rs3388896653 | 646 | P>S | No | EVA | |
| rs3388896662 | 672 | S>C | No | EVA | |
| rs257125169 | 699 | C>S | No | EVA | |
| rs3388906145 | 710 | N>K | No | EVA | |
| rs3388867159 | 727 | L>P | No | EVA |
No associated diseases with Q9Z1E4
No regional properties for Q9Z1E4
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q9Z1E4 | |||
Functions
| Description | ||
|---|---|---|
| EC Number | 2.4.1.11 | Hexosyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| inclusion body | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| glucose binding | Binding to D- or L-enantiomers of glucose. |
| glycogen (starch) synthase activity | Catalysis of the reaction: UDP-glucose + (1,4)-alpha-D-glucosyl(n) = UDP + (1,4)-alpha-D-glucosyl(n+1). |
| glycogen synthase activity, transferring glucose-1-phosphate | Catalysis of the reaction: UDP-glucose + (1,4)-alpha-D-glucosyl(n) = UMP + (1,4)-alpha-D-glucosyl(n)-glucose-1-phosphate. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| glycogen biosynthetic process | The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues. |
| glycogen metabolic process | The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages. |
| heart development | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MPLSRSLSVS | SLPGLEDWED | EFDPENAVLF | EVAWEVANKV | GGIYTVLQTK | AKVTGDEWGD |
| 70 | 80 | 90 | 100 | 110 | 120 |
| NYYLVGPYTE | QGVRTQVELL | EPPTPELKRT | LDSMNSKGCK | VYFGRWLIEG | GPLVVLLDVG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| ASAWALERWK | GELWDTCNIG | VPWYDREAND | AVLFGFLTTW | FLGEFLAQNE | EKPYVVAHFH |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EWLAGVGLCL | CRARRLPVAT | IFTTHATLLG | RYLCAGAVDF | YNNLENFNVD | KEAGERQIYH |
| 250 | 260 | 270 | 280 | 290 | 300 |
| RYCMERAAAH | CAHVFTTVSQ | ITAIEAQHLL | KRKPDIVTPN | GLNVKKFSAM | HEFQNLHAQS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KARIQEFVRG | HFYGHLDFNL | DKTLYFFIAG | RYEFSNKGAD | VFLEALARLN | YLLRVNGSEQ |
| 370 | 380 | 390 | 400 | 410 | 420 |
| TVVAFFIMPA | RTNNFNVETL | KGQAVRKQLW | DTANTVKEKF | GRKLYESLLV | GSLPDMNKML |
| 430 | 440 | 450 | 460 | 470 | 480 |
| DKEDFTMMKR | AIFATQRQSF | PPVCTHNMLD | DSSDPILTTI | RRIGLFNSSA | DRVKVIFHPE |
| 490 | 500 | 510 | 520 | 530 | 540 |
| FLSSTSPLLP | VDYEEFVRGC | HLGVFPSYYE | PWGYTPAECT | VMGIPSISTN | LSGFGCFMEE |
| 550 | 560 | 570 | 580 | 590 | 600 |
| HIADPSAYGI | YILDRRFRSL | DDSCSQLTSF | LYSFCQQSRR | QRIIQRNRTE | RLSDLLDWKY |
| 610 | 620 | 630 | 640 | 650 | 660 |
| LGRYYMSARH | MALAKAFPDH | FTYEPHEVDA | TQGYRYPRPA | SVPPSPSLSR | HSSPHQSEDE |
| 670 | 680 | 690 | 700 | 710 | 720 |
| EEPRDGPLGE | DSERYDEEEE | AAKDRRNIRA | PEWPRRASCS | SSTGGSKRSN | SVDTGPSSSL |
| 730 | |||||
| STPTEPLSPT | SSLGEERN |